Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Mahé

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Presse Medicale (Paris, France : 1983)|November 2, 1999
[How long should anticoagulants be administered in the therapy of the first episode of venous thromboembolism?]I Mahé
Presse Medicale (Paris, France : 1983)|March 17, 2000
[Médenox study]I Mahé
Presse Medicale (Paris, France : 1983)|October 19, 2000
[The ELITE 2 study]I Mahé
Presse Medicale (Paris, France : 1983)|July 8, 1999
[Heart failure: an indication for beta blockaders]I Mahé
Presse Medicale (Paris, France : 1983)|January 5, 2002
[The PROGRESS study for the prevention of recurrent cerebrovascular accident]I Mahé
Presse Medicale (Paris, France : 1983)|November 28, 2001
[What kind of heparin treatment in venous thromboembolic disease?]I Mahé
Presse Medicale (Paris, France : 1983)|May 6, 1999
[What is the role of pravastatin in the secondary prevention of coronary disease?]I Mahé
La Revue De Medecine Interne|March 23, 2013
[Anticoagulant clinics in France? Which usefulness now and for the future?]I Mahé
Presse Medicale (Paris, France : 1983)|February 25, 2000
[The RALES study]I Mahé
Presse Medicale (Paris, France : 1983)|July 4, 2001
[Primary cardiovascular prevention: aspirin, vitamin E or placebo]I Mahé
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Presse Medicale (Paris, France : 1983)|November 2, 1999
[How long should anticoagulants be administered in the therapy of the first episode of venous thromboembolism?]I Mahé
Presse Medicale (Paris, France : 1983)|March 17, 2000
[Médenox study]I Mahé
Presse Medicale (Paris, France : 1983)|October 19, 2000
[The ELITE 2 study]I Mahé
Presse Medicale (Paris, France : 1983)|July 8, 1999
[Heart failure: an indication for beta blockaders]I Mahé
Presse Medicale (Paris, France : 1983)|January 5, 2002
[The PROGRESS study for the prevention of recurrent cerebrovascular accident]I Mahé
Presse Medicale (Paris, France : 1983)|November 28, 2001
[What kind of heparin treatment in venous thromboembolic disease?]I Mahé
Presse Medicale (Paris, France : 1983)|May 6, 1999
[What is the role of pravastatin in the secondary prevention of coronary disease?]I Mahé
La Revue De Medecine Interne|March 23, 2013
[Anticoagulant clinics in France? Which usefulness now and for the future?]I Mahé
Presse Medicale (Paris, France : 1983)|February 25, 2000
[The RALES study]I Mahé
Presse Medicale (Paris, France : 1983)|July 4, 2001
[Primary cardiovascular prevention: aspirin, vitamin E or placebo]I Mahé
Pageof 8